Table 1. Patient population: all treated patients (N=64).
| Characteristics | N (%) |
|---|---|
|
Gender | |
| Female | 36 (56) |
| Male |
28 (44) |
| Median age: years (range) |
56.5 (25–75) |
|
Cancer types | |
| Colorectal | 28 (44) |
| GI (non-colorectal) | 10 (16) |
| Breast | 9 (14) |
| Skin melanoma | 5 (8) |
| Head/neck | 2 (3) |
| Lung | 1 (2) |
| Othersa |
8 (12) |
|
Baseline WHO PS | |
| 0 | 29 (45) |
| 1 | 34 (53) |
| 2 |
1 (2) |
|
Prior antineoplastic therapy | |
| Yes | 64 (100) |
| No |
0 |
|
Therapy type at last treatment | |
| Chemotherapy | 41 (64) |
| Hormone therapy | 1 (2) |
| Targeted therapy | 24 (53) |
| Othera |
4 (6) |
|
Number of prior treatments | |
| 1–2 | 11 (17) |
| 3–4 | 32 (50) |
| >4 | 21 (33) |
Abbreviations: GI=gastrointestinal; GIST=gastrointestinal stromal tumour; WHO PS=World Health Organisation performance status.
a
Others include: ovary, kidney, sarcoma, thyroid, uveal melanoma and GIST.